Unraveling the Link between Ιnsulin Resistance and Bronchial Asthma

Author:

Bartziokas Konstantinos1ORCID,Papaioannou Andriana I.2,Drakopanagiotakis Fotios3ORCID,Gouveri Evanthia4,Papanas Nikolaos4ORCID,Steiropoulos Paschalis3ORCID

Affiliation:

1. Private Pulmonologist, 42132 Trikala, Greece

2. 1st University Department of Respiratory Medicine, “Sotiria” Hospital, National and Kapodistrian University of Athens, 15772 Athens, Greece

3. Department of Pneumonology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece

4. Diabetes Centre, 2nd Department of Internal Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece

Abstract

Evidence from large epidemiological studies has shown that obesity may predispose to increased Th2 inflammation and increase the odds of developing asthma. On the other hand, there is growing evidence suggesting that metabolic dysregulation that occurs with obesity, and more specifically hyperglycemia and insulin resistance, may modify immune cell function and in some degree systemic inflammation. Insulin resistance seldom occurs on its own, and in most cases constitutes a clinical component of metabolic syndrome, along with central obesity and dyslipidemia. Despite that, in some cases, hyperinsulinemia associated with insulin resistance has proven to be a stronger risk factor than body mass in developing asthma. This finding has been supported by recent experimental studies showing that insulin resistance may contribute to airway remodeling, promotion of airway smooth muscle (ASM) contractility and proliferation, increase of airway hyper-responsiveness and release of pro-inflammatory mediators from adipose tissue. All these effects indicate the potential impact of hyperinsulinemia on airway structure and function, suggesting the presence of a specific asthma phenotype with insulin resistance. Epidemiologic studies have found that individuals with severe and uncontrolled asthma have a higher prevalence of glycemic dysfunction, whereas longitudinal studies have linked glycemic dysfunction to an increased risk of asthma exacerbations. Since the components of metabolic syndrome interact with one another so much, it is challenging to identify each one’s specific role in asthma. This is why, over the last decade, additional studies have been conducted to determine whether treatment of type 2 diabetes mellitus affects comorbid asthma as shown by the incidence of asthma, asthma control and asthma-related exacerbations. The purpose of this review is to present the mechanism of action, and existing preclinical and clinical data, regarding the effect of insulin resistance in asthma.

Publisher

MDPI AG

Reference142 articles.

1. To, T., Stanojevic, S., Moores, G., Gershon, A.S., Bateman, E.D., Cruz, A.A., and Boulet, L.-P. (2012). Global Asthma Prevalence in Adults: Findings from the Cross-Sectional World Health Survey. BMC Public Health, 12.

2. GBD 2019 Chronic Respiratory Diseases Collaborators (2023). Global Burden of Chronic Respiratory Diseases and Risk Factors, 1990-2019: An Update from the Global Burden of Disease Study 2019. EClinicalMedicine, 59, 101936.

3. (2023, December 12). 2023 GINA Main Report. Available online: https://ginasthma.org/2023-gina-main-report/.

4. Manifesto on United Airways Diseases (UAD): An Interasma (global Asthma Association—GAA) Document;Tiotiu;J. Asthma,2022

5. Recent Insights in the Role of Biomarkers in Severe Asthma Management;Fouka;Front. Med.,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3